
Jose Maldonado, MD, FACLP
Professor & Associate Chair, Department of Psychiatry
Stanford University

Delirium
Saturday, February 13, 2027
8:00 AM - 9:00 AM
Dr. Maldonado is the John & Terry Levin Family Endowed Professor of Medicine, Associate Chair – Department of Psychiatry, Chief of the Division of Medical Psychiatry, and Medical Director of the Critical Care Psychiatry Service at Stanford School of Medicine. He is board-certified in Adult Psychiatry, Consult-Liaison Psychiatry, Forensic Psychiatry, Addiction Medicine, and Forensic Medicine, with a focus on the interface of psychiatry, medicine, and neurology and the neurobehavioral complications of medical illness and neurological disorders.
A former President and current Board member of the American Delirium Society, he led the creation of a new specialty within Medical Psychiatry: Critical Care Psychiatry, and is the founder and first Chair of the Critical Care Psychiatry Special Interest Group at the Academy of Consultation-Liaison Psychiatry; he is also editor-in-chief of an anticipated definitive book on the field with American Psychiatric Press. A Stanford faculty member for 32 years, he built the Division of Medical Psychiatry, collaborated with all organ transplant services, chaired the Stanford Medicine Faculty Senate, and served on the Medical Executive Committee and other committees. He established the nation’s first Critical Care Psychiatry Service, a model for other programs and a source of staff support during crises. His Medical Psychiatry Research Lab has developed sixteen clinical instruments and numerous clinical protocols, including SIPAT for transplant candidacy; the Stanford Proxy Test of Delirium (S-PTD), which outperformed CAM against DSM-5 criteria (94% vs 23%); SAPD for delirium risk; and PAWSS for alcohol withdrawal severity. The lab leads more than a dozen ongoing projects. He has 200+ peer-reviewed publications, and contributed 60+ chapters, mentoring hundreds of colleagues. Awards include the Sawl ow Memorial Award, the 2017 Franz-Köhler-Inflammation-Award, the 2018 Hackett Memorial Award (ACLP; first Hispanic recipient), the inaugural John & Terry Levin Professorship (2023), and the 2024 Dlin/Fischer Award (three-time recipient).
Lecture Summary:
This presentation will provide a comprehensive review of delirium, including its epidemiology, clinical features, subtypes, risk factors, and associated morbidity and mortality. The session will examine current understanding of the neurobiology of delirium, commonly used screening and assessment tools, and emerging technologies that may support detection. It will also address the relationship between delirium and subsequent cognitive outcomes, along with evidence-based nonpharmacologic and pharmacologic approaches to management. Case discussion will be used to reinforce practical strategies for recognizing and treating delirium in clinical practice.
Goals and Learning Objectives:
-
Review the clinical characteristics of delirium subtypes
-
Discuss the screening instruments available for the detection of delirium
-
Review the data supporting the use of pharmacological agents for the management of delirium
Disclosures:
This presentation has no relevant disclosures to provide.
.png)